CLSPN | claspin | 1p34.3 | 0.415 | 0.637 | 0
|
PRR11 | proline rich 11 | 17q23.2 | 0.394 | 0.635 | 0
|
INCENP | inner centromere protein antigens 135/155kDa | 11q12.3 | 0.386 | 0.612 | 0
|
KLHDC10 | kelch domain containing 10 | 7q32.2 | 0.386 | 0.5 | 0
|
CASC5 | cancer susceptibility candidate 5 | 15q14 | 0.376 | 0.606 | 0
|
NCAPD2 | non-SMC condensin I complex, subunit D2 | 12p13.31 | 0.376 | 0.584 | 0
|
RIF1 | replication timing regulatory factor 1 | 2q23.3 | 0.373 | 0.57 | 0
|
FAM168A | family with sequence similarity 168, member A | 11q13.4 | 0.369 | 0.511 | 0
|
STIL | SCL/TAL1 interrupting locus | 1p32 | 0.369 | 0.568 | 0
|
SOCS7 | suppressor of cytokine signaling 7 | 17q12 | 0.368 | 0.522 | 0
|
PLK1 | polo-like kinase 1 | 16p | 0.365 | 0.522 | 0
|
USP1 | ubiquitin specific peptidase 1 | 1p31.3 | 0.365 | 0.565 | 0
|
FOXM1 | forkhead box M1 | 12p13 | 0.364 | 0.541 | 0
|
RBL1 | retinoblastoma-like 1 | 20q11.23 | 0.364 | 0.574 | 0
|
NOP9 | NOP9 nucleolar protein | 14q12 | 0.362 | 0.529 | 0
|
NUP153 | nucleoporin 153kDa | 6p22.3 | 0.36 | 0.486 | 0
|
SMC2 | structural maintenance of chromosomes 2 | 9q31.1 | 0.359 | 0.581 | 0
|
ARHGAP11B | Rho GTPase activating protein 11B | 15q13.2 | 0.359 | 0.573 | 0
|
CENPO | centromere protein O | 2p23.3 | 0.356 | 0.53 | 0
|
DHX9 | DEAH (Asp-Glu-Ala-His) box helicase 9 | 1q25 | 0.356 | 0.563 | 0
|
NUP160 | nucleoporin 160kDa | 11p11.12 | 0.354 | 0.501 | 0
|
CHAMP1 | chromosome alignment maintaining phosphoprotein 1 | 13q34 | 0.352 | 0.547 | 0
|
UBXN7 | UBX domain protein 7 | 3q29 | 0.352 | 0.543 | 0
|
GAS2L3 | growth arrest-specific 2 like 3 | 12q23.1 | 0.352 | 0.571 | 0
|
HNRNPR | heterogeneous nuclear ribonucleoprotein R | 1p36.12 | 0.351 | 0.548 | 0
|
CCDC159 | coiled-coil domain containing 159 | 19p13.2 | 0.35 | -0.536 | 0
|
PFDN5 | prefoldin subunit 5 | 12q13.13 | 0.35 | -0.567 | 0
|
RBBP5 | retinoblastoma binding protein 5 | 1q32 | 0.349 | 0.551 | 0
|
TIMELESS | timeless circadian clock | 12q13.3 | 0.347 | 0.569 | 0
|
BRCA2 | breast cancer 2, early onset | 13q13.1 | 0.347 | 0.556 | 0
|
KIF18B | kinesin family member 18B | 17q21.31 | 0.347 | 0.526 | 0
|
SAMD4B | sterile alpha motif domain containing 4B | 19q13.2 | 0.347 | 0.558 | 0
|
KIAA1958 | KIAA1958 | 9q33.1 | 0.346 | 0.499 | 0
|
PRKDC | protein kinase, DNA-activated, catalytic polypeptide | 8q11 | 0.346 | 0.563 | 0
|
BRCA1 | breast cancer 1, early onset | 17q21.31 | 0.345 | 0.527 | 0
|
SMC1A | structural maintenance of chromosomes 1A | Xp11.22-p11.21 | 0.343 | 0.56 | 0
|
NSD1 | nuclear receptor binding SET domain protein 1 | 5q35 | 0.342 | 0.493 | 0
|
NUP155 | nucleoporin 155kDa | 5p13.1 | 0.342 | 0.594 | 0
|
NUP205 | nucleoporin 205kDa | 7q31.32 | 0.342 | 0.558 | 0
|
PRRC2B | proline-rich coiled-coil 2B | 9q34.13 | 0.34 | 0.548 | 0
|
ATAD5 | ATPase family, AAA domain containing 5 | 17q11.2 | 0.34 | 0.501 | 0
|
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | 19p13.2 | 0.34 | 0.589 | 0
|
TOPBP1 | topoisomerase (DNA) II binding protein 1 | 3q22.1 | 0.339 | 0.594 | 0
|
POLR3A | polymerase (RNA) III (DNA directed) polypeptide A, 155kDa | 10q22.3 | 0.339 | 0.488 | 0
|
BAZ1B | bromodomain adjacent to zinc finger domain, 1B | 7q11.23 | 0.339 | 0.534 | 0
|
GTF3C4 | general transcription factor IIIC, polypeptide 4, 90kDa | 9q34.3 | 0.338 | 0.54 | 0
|
GSG2 | germ cell associated 2 (haspin) | 17p13 | 0.338 | 0.549 | 0
|
MCM4 | minichromosome maintenance complex component 4 | 8q12-q13 | 0.337 | 0.545 | 0
|
GTSE1 | G-2 and S-phase expressed 1 | 22q13.2-q13.3 | 0.336 | 0.517 | 0
|
CXorf56 | chromosome X open reading frame 56 | Xq24 | 0.336 | 0.517 | 0
|
SYNC | syncoilin, intermediate filament protein | 1p35.1 | 0.336 | -0.554 | 0
|
TMPO | thymopoietin | 12q22 | 0.332 | 0.51 | 0
|
GNA11 | guanine nucleotide binding protein (G protein), alpha 11 (Gq class) | 19p13.3 | 0.33 | 0.507 | 0
|
RGP1 | RGP1 homolog, RAB6A GEF complex partner 1 | 9p13.3 | 0.328 | 0.514 | 0
|
CEP85 | centrosomal protein 85kDa | 1p36.11 | 0.327 | 0.551 | 0
|
URB2 | URB2 ribosome biogenesis 2 homolog (S. cerevisiae) | 1q42.13 | 0.327 | 0.533 | 0
|
C9orf129 | chromosome 9 open reading frame 129 | 9q22.31 | 0.326 | 0.527 | 0
|
KIAA0100 | KIAA0100 | 17q11.2 | 0.326 | 0.499 | 0
|
SNRNP200 | small nuclear ribonucleoprotein 200kDa (U5) | 2q11.2 | 0.324 | 0.556 | 0
|
MTF1 | metal-regulatory transcription factor 1 | 1p33 | 0.323 | 0.447 | 0
|
MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 1p36 | 0.322 | 0.526 | 0
|
ADAR | adenosine deaminase, RNA-specific | 1q21.3 | 0.322 | 0.484 | 0
|
MAML1 | mastermind-like transcriptional coactivator 1 | 5q35 | 0.321 | 0.44 | 0
|
POLR1A | polymerase (RNA) I polypeptide A, 194kDa | 2p11.2 | 0.321 | 0.547 | 0
|
ORC1 | origin recognition complex, subunit 1 | 1p32 | 0.321 | 0.561 | 0
|
KIF1B | kinesin family member 1B | 1p36.22 | 0.321 | 0.492 | 0
|
HIRA | histone cell cycle regulator | 22q11.2 | 0.321 | 0.511 | 0
|
ZNF106 | zinc finger protein 106 | 15q15.1 | 0.32 | 0.495 | 0
|
ANAPC1 | anaphase promoting complex subunit 1 | 2q12.1 | 0.32 | 0.532 | 0
|
GNPTG | N-acetylglucosamine-1-phosphate transferase, gamma subunit | 16p13.3 | 0.317 | -0.507 | 0
|
CSTF2 | cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa | Xq22.1 | 0.316 | 0.488 | 0
|
CELF1 | CUGBP, Elav-like family member 1 | 11p11 | 0.316 | 0.481 | 0
|
SNRNP40 | small nuclear ribonucleoprotein 40kDa (U5) | 1p35.2 | 0.316 | 0.446 | 0
|
CD63 | CD63 molecule | 12q12-q13 | 0.316 | -0.465 | 0
|
FAM168B | family with sequence similarity 168, member B | 2q21.1 | 0.315 | 0.451 | 0
|
RMI1 | RecQ mediated genome instability 1 | 9q22.1 | 0.314 | 0.506 | 0
|
CAD | carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 2p22-p21 | 0.314 | 0.516 | 0
|
RPL34 | ribosomal protein L34 | 4q25 | 0.313 | -0.468 | 0
|
SP2 | Sp2 transcription factor | 17q21.3-q22 | 0.313 | 0.548 | 0
|
HNRNPM | heterogeneous nuclear ribonucleoprotein M | 19p13.2 | 0.312 | 0.496 | 0
|
ZBTB6 | zinc finger and BTB domain containing 6 | 9q33.1-q33.3 | 0.311 | 0.43 | 0
|
FANCC | Fanconi anemia, complementation group C | 9q22.3 | 0.311 | 0.458 | 0
|
ANKRD52 | ankyrin repeat domain 52 | 12q13.3 | 0.309 | 0.503 | 0
|
EIF4G1 | eukaryotic translation initiation factor 4 gamma, 1 | 3q27.1 | 0.308 | 0.501 | 0
|
DKC1 | dyskeratosis congenita 1, dyskerin | Xq28 | 0.307 | 0.438 | 0
|
ARHGAP35 | Rho GTPase activating protein 35 | 19q13.32 | 0.307 | 0.51 | 0
|
GATC | glutamyl-tRNA(Gln) amidotransferase, subunit C | 12q24.31 | 0.306 | 0.477 | 0
|
ARPC3 | actin related protein 2/3 complex, subunit 3, 21kDa | 12q24 | 0.304 | -0.428 | 0
|
MCTS2P | malignant T cell amplified sequence 2, pseudogene | 20q11.21 | 0.304 | 0.511 | 0
|
IRAK1 | interleukin-1 receptor-associated kinase 1 | Xq28 | 0.302 | 0.503 | 0
|
BRPF3 | bromodomain and PHD finger containing, 3 | 6p21.31 | 0.302 | 0.486 | 0
|
PARP1 | poly (ADP-ribose) polymerase 1 | 1q41-q42 | 0.3 | 0.462 | 0
|
USP42 | ubiquitin specific peptidase 42 | 7p22.2 | 0.3 | 0.529 | 0
|
CBX2 | chromobox homolog 2 | 17q25.3 | 0.299 | 0.426 | 0
|
DPH2 | DPH2 homolog | 1p34 | 0.297 | 0.481 | 0
|
BEND3 | BEN domain containing 3 | 6q21 | 0.293 | 0.509 | 0
|
CBY1 | chibby homolog 1 (Drosophila) | 22q12 | 0.292 | -0.366 | 6.08e-15
|
NONO | non-POU domain containing, octamer-binding | Xq13.1 | 0.292 | 0.418 | 0
|
GCN1 | GCN1 eIF2 alpha kinase activator homolog | 12q24.23 | 0.29 | 0.406 | 0
|
GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | Xp11.22 | 0.287 | 0.42 | 0
|
ZNF646 | zinc finger protein 646 | 16p11.2 | 0.287 | 0.441 | 0
|
EHMT1 | euchromatic histone-lysine N-methyltransferase 1 | 9q34.3 | 0.286 | 0.442 | 0
|
UBN1 | ubinuclein 1 | 16p13.3 | 0.284 | 0.486 | 0
|
PRRC2A | proline-rich coiled-coil 2A | 6p21.3 | 0.283 | 0.472 | 0
|
LLGL1 | lethal giant larvae homolog 1 (Drosophila) | 17p11.2 | 0.28 | 0.47 | 0
|
VBP1 | von Hippel-Lindau binding protein 1 | Xq28 | 0.28 | 0.401 | 0
|
RBM14 | RNA binding motif protein 14 | 11q13.2 | 0.278 | 0.495 | 0
|
GMEB1 | glucocorticoid modulatory element binding protein 1 | 1p35 | 0.278 | 0.408 | 0
|
ZNF592 | zinc finger protein 592 | 15q25.2 | 0.277 | 0.435 | 0
|
SMG5 | SMG5 nonsense mediated mRNA decay factor | 1q21 | 0.277 | 0.42 | 0
|
COMT | catechol-O-methyltransferase | 22q11.21 | 0.276 | -0.312 | 5.5e-11
|
KDM5C | lysine (K)-specific demethylase 5C | Xp11.22-p11.21 | 0.275 | 0.349 | 1.5e-13
|
ARHGAP19 | Rho GTPase activating protein 19 | 10q24.2 | 0.275 | 0.47 | 0
|
DDX23 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 | 12q13.11 | 0.275 | 0.413 | 0
|
CANT1 | calcium activated nucleotidase 1 | 17q25.3 | 0.275 | 0.372 | 1.78e-15
|
TTI1 | TELO2 interacting protein 1 | 20q11.23 | 0.274 | 0.385 | 2.19e-17
|
NOL9 | nucleolar protein 9 | 1p36.31 | 0.272 | 0.457 | 0
|
HSPA8 | heat shock 70kDa protein 8 | 11q24.1 | 0.272 | 0.39 | 0
|
VASH2 | vasohibin 2 | 1q23 | 0.272 | 0.153 | 0.00151
|
CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 17q12 | 0.272 | 0.417 | 0
|
SOAT1 | sterol O-acyltransferase 1 | 1q25 | 0.271 | 0.247 | 2.59e-07
|
DOT1L | DOT1-like histone H3K79 methyltransferase | 19p13.3 | 0.271 | 0.432 | 0
|
REEP5 | receptor accessory protein 5 | 5q22-q23 | 0.27 | -0.433 | 0
|
TCEAL4 | transcription elongation factor A (SII)-like 4 | Xq22.2 | 0.27 | -0.456 | 0
|
NUP62 | nucleoporin 62kDa | 19q13.33 | 0.269 | 0.489 | 0
|
MCM3AP-AS1 | MCM3AP antisense RNA 1 | 21q22.3 | 0.269 | 0.405 | 0
|
KDM2B | lysine (K)-specific demethylase 2B | 12q24.31 | 0.268 | 0.386 | 9.84e-18
|
MAFG | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G | 17q25.3 | 0.268 | 0.4 | 0
|
SPHAR | S-phase response (cyclin related) | 1q42.13 | 0.266 | -0.466 | 0
|
CASC3 | cancer susceptibility candidate 3 | 17q21.1 | 0.265 | 0.34 | 7.25e-13
|
CD3EAP | CD3e molecule, epsilon associated protein | 19q13.3 | 0.263 | 0.419 | 0
|
GADD45B | growth arrest and DNA-damage-inducible, beta | 19p13.3 | 0.261 | -0.359 | 2.44e-14
|
CHTF8 | chromosome transmission fidelity factor 8 | 16q22.1 | 0.261 | 0.454 | 0
|
UBE2O | ubiquitin-conjugating enzyme E2O | 17q25.1 | 0.259 | 0.345 | 3.23e-13
|
MPV17 | MpV17 mitochondrial inner membrane protein | 2p23.3 | 0.258 | -0.426 | 0
|
MED22 | mediator complex subunit 22 | 9q34.1 | 0.257 | 0.374 | 1.26e-15
|
RAB35 | RAB35, member RAS oncogene family | 12q24 | 0.256 | 0.279 | 4.91e-09
|
DHX37 | DEAH (Asp-Glu-Ala-His) box polypeptide 37 | 12q24.31 | 0.256 | 0.404 | 0
|
CHD4 | chromodomain helicase DNA binding protein 4 | 12p13 | 0.255 | 0.426 | 0
|
NMRK1 | nicotinamide riboside kinase 1 | 9q21.31 | 0.253 | -0.338 | 1.01e-12
|
METTL13 | methyltransferase like 13 | 1q24-q25.3 | 0.253 | 0.406 | 0
|
GSTK1 | glutathione S-transferase kappa 1 | 7q34 | 0.252 | -0.352 | 8.86e-14
|
LRRC70 | leucine rich repeat containing 70 | 5q12.1 | 0.252 | -0.36 | 2.12e-14
|
TLX3 | T-cell leukemia homeobox 3 | 5q35.1 | 0.251 | 0.05 | 0.306
|
SETD1A | SET domain containing 1A | 16p11.2 | 0.25 | 0.263 | 3.8e-08
|
C14orf28 | chromosome 14 open reading frame 28 | 14q21.2 | 0.25 | -0.419 | 0
|
TCHP | trichoplein, keratin filament binding | 12q24.11 | 0.248 | 0.272 | 1.29e-08
|
C14orf159 | chromosome 14 open reading frame 159 | 14q32.11 | 0.248 | -0.286 | 2.14e-09
|
TECPR1 | tectonin beta-propeller repeat containing 1 | 7q21.3 | 0.246 | 0.412 | 0
|
PI4KA | phosphatidylinositol 4-kinase, catalytic, alpha | 22q11.21 | 0.242 | 0.358 | 3.37e-14
|
TBC1D24 | TBC1 domain family, member 24 | 16p13.3 | 0.241 | 0.423 | 0
|
RAB43 | RAB43, member RAS oncogene family | 3q21.3 | 0.241 | 0.366 | 6.37e-15
|
NPLOC4 | NPL4 homolog, ubiquitin recognition factor | 17q25.3 | 0.24 | 0.432 | 0
|
LETM2 | leucine zipper-EF-hand containing transmembrane protein 2 | 8p11.23 | 0.239 | -0.081 | 0.0944
|
RPTOR | regulatory associated protein of MTOR, complex 1 | 17q25.3 | 0.238 | 0.386 | 7.3e-18
|
PSKH1 | protein serine kinase H1 | 16q22.1 | 0.237 | 0.349 | 1.58e-13
|
ERCC3 | excision repair cross-complementation group 3 | 2q21 | 0.237 | 0.301 | 2.76e-10
|
KIAA0226 | RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein | 3q29 | 0.235 | 0.375 | 8.61e-16
|
PCNXL3 | pecanex-like 3 (Drosophila) | 11q12.1 | 0.234 | 0.413 | 0
|
RNF216 | ring finger protein 216 | 7p22.1 | 0.233 | 0.409 | 0
|
MURC | muscle-related coiled-coil protein | 9q31.1 | 0.23 | 0.259 | 6.41e-08
|
SYT8 | synaptotagmin VIII | 11p15.5 | 0.228 | -0.247 | 2.68e-07
|
CCDC53 | coiled-coil domain containing 53 | 12q23.3 | 0.227 | -0.408 | 0
|
SPTBN2 | spectrin, beta, non-erythrocytic 2 | 11q13.2 | 0.226 | 0.321 | 1.38e-11
|
MCM3AP | minichromosome maintenance complex component 3 associated protein | 21q22.3 | 0.226 | 0.328 | 4.95e-12
|
WDR33 | WD repeat domain 33 | 2q21.1 | 0.225 | 0.354 | 6.31e-14
|
FNDC8 | fibronectin type III domain containing 8 | 17q12 | 0.225 | 0.312 | 5.48e-11
|
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 19q13.1-q13.2 | 0.223 | 0.334 | 1.78e-12
|
TYRO3 | TYRO3 protein tyrosine kinase | 15q15.1-q21.1 | 0.223 | 0.312 | 5.34e-11
|
CIC | capicua transcriptional repressor | 19q13.2 | 0.222 | 0.342 | 5.16e-13
|
SH3BP5L | SH3-binding domain protein 5-like | 1q44 | 0.219 | 0.309 | 8.31e-11
|
GMEB2 | glucocorticoid modulatory element binding protein 2 | 20q13.33 | 0.212 | 0.278 | 5.89e-09
|
ADCY1 | adenylate cyclase 1 (brain) | 7p12.3 | 0.211 | 0.142 | 0.00321
|
INTS1 | integrator complex subunit 1 | 7p22.3 | 0.209 | 0.372 | 2.05e-15
|
SPCS2 | signal peptidase complex subunit 2 | 11q13.4 | 0.209 | -0.295 | 6.47e-10
|
CCDC97 | coiled-coil domain containing 97 | 19q13.2 | 0.207 | 0.333 | 2.12e-12
|
IP6K1 | inositol hexakisphosphate kinase 1 | 3p21.31 | 0.205 | 0.287 | 1.91e-09
|
AP2A1 | adaptor-related protein complex 2, alpha 1 subunit | 19q13.33 | 0.204 | 0.308 | 9.47e-11
|
RAP1B | RAP1B, member of RAS oncogene family | 12q14 | 0.203 | -0.22 | 4.52e-06
|
SLC38A6 | solute carrier family 38, member 6 | 14q23.1 | 0.2 | -0.244 | 3.64e-07
|
RMDN1 | regulator of microtubule dynamics 1 | 8q21.3 | 0.197 | -0.157 | 0.00119
|
COBL | cordon-bleu WH2 repeat protein | 7p12.2-p12.1 | 0.194 | 0.066 | 0.176
|
DAGLA | diacylglycerol lipase, alpha | 11q12.3 | 0.194 | 0.241 | 4.86e-07
|